Literature DB >> 19097198

Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.

John M Pearce1, Richard A Komoroski, Robert E Mrak.   

Abstract

Cell membrane abnormalities due to changes in phospholipid (PL) composition and metabolism have been implicated in schizophrenia pathogenesis. That work has generally assessed membrane phospholipids from nonneural tissues such as erythrocytes and platelets. High-resolution (31)P NMR spectroscopy was used to characterize PLs of gray matter in postmortem brain for 20 schizophrenics, 20 controls, and 7 patients with other mental illnesses (psychiatric controls). Tissues from frontal, temporal, and occipital cortices were extracted with hexane-isopropanol, and (31)P NMR spectra were obtained in an organic-solvent system to resolve the major PL classes (based on headgroups) and subclasses (based on linkage at the sn - 1 position). Surprisingly, repeated-measures multivariate analysis of variance revealed no overall differences among the groups. There were no significant differences (P < .05) among the three groups for any individual PL subclass, including lysophospholipids. The sum of all phosphatidylethanolamine headgroups was significantly lower for schizophrenics than for controls or psychiatric controls in the frontal cortex. The present results are minimally correlated with previous results for aqueous PL metabolites on these same samples. The metabolite changes measured by in vivo (31)P MRS in schizophrenia do not appear to reflect PL concentration changes. The present results offer very little support for the phospholipid hypothesis of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19097198      PMCID: PMC2610237          DOI: 10.1002/mrm.21820

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  34 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  Increased platelet membrane lysophosphatidylcholine in schizophrenia.

Authors:  A M Pangerl; A Steudle; H W Jaroni; R Rüfer; W F Gattaz
Journal:  Biol Psychiatry       Date:  1991-10-15       Impact factor: 13.382

Review 3.  Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications.

Authors:  Sahebarao P Mahadik; Denise R Evans
Journal:  Psychiatr Clin North Am       Date:  2003-03

4.  Diagnostic criteria for use in psychiatric research.

Authors:  J P Feighner; E Robins; S B Guze; R A Woodruff; G Winokur; R Munoz
Journal:  Arch Gen Psychiatry       Date:  1972-01

5.  Phosphorus NMR analysis of phospholipids in detergents.

Authors:  E London; G W Feigenson
Journal:  J Lipid Res       Date:  1979-03       Impact factor: 5.922

6.  Lipid composition of the normal human brain: gray matter, white matter, and myelin.

Authors:  J S O'Brien; E L Sampson
Journal:  J Lipid Res       Date:  1965-10       Impact factor: 5.922

7.  Increased concentrations of phosphatidylinositol (PI) and decreased esterification of arachidonic acid into phospholipids in platelets from patients with schizoaffective disorders or atypic phasic psychoses.

Authors:  L Demisch; K Heinz; H Gerbaldo; R Kirsten
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1992-05       Impact factor: 4.006

8.  Increased turnover of platelet phosphatidylinositol in schizophrenia.

Authors:  J K Yao; P Yasaei; D P van Kammen
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1992-05       Impact factor: 4.006

9.  Altered thalamic membrane phospholipids in schizophrenia: a postmortem study.

Authors:  Andrea Schmitt; Katrin Wilczek; Kaj Blennow; Athanasios Maras; Alexander Jatzko; Georg Petroianu; Dieter F Braus; Wagner F Gattaz
Journal:  Biol Psychiatry       Date:  2004-07-01       Impact factor: 13.382

Review 10.  Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia.

Authors:  Ravinder Reddy; Matcheri S Keshavan
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2003-12       Impact factor: 4.006

View more
  6 in total

1.  Lipidomic analysis of porcine olfactory epithelial membranes and cilia.

Authors:  Simona Lobasso; Patrizia Lopalco; Roberto Angelini; Maristella Baronio; Francesco P Fanizzi; Francesco Babudri; Angela Corcelli
Journal:  Lipids       Date:  2010-05-29       Impact factor: 1.880

2.  Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients.

Authors:  Ameer Y Taha; Yewon Cheon; Kaizong Ma; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Psychiatr Res       Date:  2013-02-18       Impact factor: 4.791

3.  Oxidative stress in schizophrenia.

Authors:  Marija Bošković; Tomaž Vovk; Blanka Kores Plesničar; Iztok Grabnar
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

4.  Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia.

Authors:  Matej Orešič; Tuulikki Seppänen-Laakso; Daqiang Sun; Jing Tang; Sebastian Therman; Rachael Viehman; Ulla Mustonen; Theo G van Erp; Tuulia Hyötyläinen; Paul Thompson; Arthur W Toga; Matti O Huttunen; Jaana Suvisaari; Jaakko Kaprio; Jouko Lönnqvist; Tyrone D Cannon
Journal:  Genome Med       Date:  2012-01-18       Impact factor: 11.117

5.  Decreased 16:0/20:4-phosphatidylinositol level in the post-mortem prefrontal cortex of elderly patients with schizophrenia.

Authors:  Junya Matsumoto; Hiroki Nakanishi; Yasuto Kunii; Yuki Sugiura; Dai Yuki; Akira Wada; Mizuki Hino; Shin-Ichi Niwa; Takeshi Kondo; Michihiko Waki; Takahiro Hayasaka; Noritaka Masaki; Hiroyasu Akatsu; Yoshio Hashizume; Sakon Yamamoto; Shinji Sato; Takehiko Sasaki; Mitsutoshi Setou; Hirooki Yabe
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

6.  Increased PLA2 activity in individuals at ultra-high risk for psychosis.

Authors:  Leda L Talib; Alana C Costa; Helena P G Joaquim; Cícero A C Pereira; Martinus T Van de Bilt; Alexandre A Loch; Wagner F Gattaz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-03-06       Impact factor: 5.270

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.